Literature DB >> 21304143

HIV and age do not substantially interact in HIV-associated neurocognitive impairment.

Lucette A Cysique1, Paul Maruff, Margaret P Bain, Edwina Wright, Bruce J Brew.   

Abstract

The authors investigated the combined age and HIV effects on cognitive functions in 146 individuals, 116 of whom had HIV infection. Forty-two percent had HIV-associated neurocognitive disorder, and all were receiving highly active antiretroviral therapy. Using linear and nonlinear regression modeling, the authors found only a trending effect of the quadratic term HIV status × age, both including dementia cases (p=0.12) and excluding dementia cases (p<0.06). Our results suggest that either this early-2000 cohort is not old enough to detect a clear interactive age and HIV effect or that there may be a survivor bias for individuals with long-term infection. Further longitudinal studies are warranted.

Entities:  

Mesh:

Year:  2011        PMID: 21304143     DOI: 10.1176/jnp.23.1.jnp83

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  25 in total

1.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

2.  Mechanisms of Cognitive Aging in the HIV-Positive Adult.

Authors:  Asante Kamkwalala; Paul Newhouse
Journal:  Curr Behav Neurosci Rep       Date:  2017-07-19

3.  Factors related to HIV-associated neurocognitive impairment differ with age.

Authors:  Gary B Fogel; Susanna L Lamers; Andrew J Levine; Miguel Valdes-Sueiras; Michael S McGrath; Paul Shapshak; Elyse J Singer
Journal:  J Neurovirol       Date:  2014-11-18       Impact factor: 2.643

Review 4.  Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.

Authors:  Ramona Bhatia; Patrick Ryscavage; Babafemi Taiwo
Journal:  J Neurovirol       Date:  2011-12-29       Impact factor: 2.643

Review 5.  CSF penetration by antiretroviral drugs.

Authors:  Christine Eisfeld; Doris Reichelt; Stefan Evers; Ingo Husstedt
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

6.  Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2011-03-17       Impact factor: 2.643

Review 7.  HIV and aging: effects on the central nervous system.

Authors:  Silvia Cañizares; Mariana Cherner; Ronald J Ellis
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

8.  Aging and HIV/AIDS: neurocognitive implications for older HIV-positive Latina/o adults.

Authors:  Monica Rivera Mindt; Caitlin Miranda; Alyssa Arentoft; Desiree Byrd; Jennifer Monzones; Armando Fuentes; Francesca Arias; Miguel Arce Rentería; Ana Rosario; Susan Morgello
Journal:  Behav Med       Date:  2014       Impact factor: 3.104

9.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

10.  Mapping white matter integrity in elderly people with HIV.

Authors:  Talia M Nir; Neda Jahanshad; Edgar Busovaca; Lauren Wendelken; Krista Nicolas; Paul M Thompson; Victor G Valcour
Journal:  Hum Brain Mapp       Date:  2013-01-30       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.